GCM
ICPT

Gladius Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Gladius Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,899
Closed -$25.5K – 401
2023
Q1 		$25.5K Sell
1,899
-666
-26% -$8.95K ﹤0.01% 226
2022
Q4 		$31.7K Buy
+2,565
New +$31.7K ﹤0.01% 244